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Benzyl alcohol is frequently used as an antimicrobial preservative or co-solvent in a
variety of pharmaceutical injection formulations. The main toxic oxidation product, benz-
aldehyde, arises from the oxidation of benzyl alcohol upon long-term storage or heat
sterilization of parenteral dosage forms containing benzyl alcohol, if oxygen is not ex-
cluded by nitrogen flushing. The presence of this potential impurity needs to be moni-
tored owing to its reactivity and toxicity (1).
Several methods have been reported for the quantitative determination of benzyl al-
cohol in parenterals, which include spectrophotometry (2, 3), gas chromatography (4, 5),
HPLC (4, 6, 7). The United States Pharmacopoeia (8) limits the presence of benzaldehyde
in benzyl alcohol to a level of 0.2%, when determined by the HPLC method.
The British Pharmacopoeia (9) states that benzyl alcohol intended for use in the ma-
nufacture of parenteral dosage forms should not contain more than 0.05% benzaldehyde
and describes a GC method for its determination in the raw material. Different methods
231
Acta Pharm. 57 (2007) 231–239 Short communication
10.2478/v10007-007-0019-3
Micellar liquid chromatographic analysis of benzyl alcohol





Faculty of Pharmacy, Department
of Analytical Chemistry, University
of Mansoura, Mansoura-35510, Egypt
Accepted February 5, 2007
An accurate, sensitive and selective reversed-phase mi-
cellar liquid chromatographic method was developed for
simultaneous determination of benzyl alcohol and benz-
aldehyde. This method was applied in different injectable
formulations containing diclofenac, piroxicam, lincomy-
cin and clindamycin. The method showed excellent line-
arity in the range of 10–100 µg mL–1 and 1–20 µg mL–1
with the limit of detection (S/N = 3) 0.25 µg mL–1 (2.3 ×
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for benzaldehyde determination in benzyl alcohol include gas chromatography (10, 11)
and liquid chromatographic methods (12, 13) as well as UV spectrometry (14–16) and
polarography (1).
In the present work, a new approach was achieved for the analysis of this preserva-
tive with or without its degradation product, benzaldehyde, by micellar liquid chroma-
tography. Different chromatographic conditions were studied in an attempt to optimize
a simple, sensitive and selective method for the evaluation of the studied compounds in
bulk and dosage forms.
EXPERIMENTAL
Materials and reagents
Benzyl alcohol (Ubichem, UK), benzaldehyde, o-phosphoric acid (Prolabo, France)
propyl paraben (Sedico, Egypt) are all analytical reagents. Methanol (Hipersolv, Merck,
Germany), 1-propanol and triethylamine (TEA) (Riedel-deHäen, Germany) are HPLC
grade reagents. Sodium dodecyl sulphate (SDS) 99% purity (Park, Scientific Limited,
UK), piroxicam raw material 99.2% purity and diclofenac sodium raw material 99.5%
purity (Sedico) were also used.
Injectable formulations investigated are (A) Feldene® (Pfizer, Egypt), (B) Disper-
cam® (Medical Union Pharmaceuticals, Egypt), both containing 20 mg mL–1 benzyl alco-
hol. (C) Feldoral® (Sedico, Egypt), (D) Voltaren® (Novartis, Egypt), both containing 40
mg mL–1 benzyl alcohol, (E) Rheumarene® (Sedico, Egypt) containing 50 mg mL–1 ben-
zyl alcohol, (F) Lincocin® and (G) Dalacin C® (Memphis, Egypt), both containing 9 mg
mL–1 benzyl alcohol.
Chromatographic conditions
Chromatographic analyses were carried out using a chromatograph model L-7100
(Merck Hitachi, Germany) equipped with an injector valve with a 20-µL loop (Rheody-
ne, USA), a L-7400 UV detector (Merck Hitachi). The chromatograms were recorded on a
D-7500 integrator (Merck Hitachi). Mobile phase was degassed using a Merck solvent
L-7612 degasser.
Apex ODS-2, C18 column (120 mm × 4.6 mm i.d., 5 mm) was used. The mobile phase
used for investigation was a solution containing 0.07 mol L–1 sodium dodecyl sulphate
and 10% 1-propanol and 0.3% triethylamine in 0.02 mol L–1 phosphoric acid of pH 7.5.
The flow rate was 1 mL min–1 and the detection wavelength was 254 nm. The internal
standard was propyl paraben.
Calibration
Stock solutions of 0.4 mg mL–1 benzyl alcohol and benzaldehyde were prepared in
methanol. Working solutions 10–100 mg mL–1 and 1–20 mg mL–1 of benzyl alcohol and
benzaldehyde, respectively, were injected together with internal standard (5 mg mL–1 of
propyl paraben, prepared from the stock solution of 0.04 mg mL–1). 20 µL aliquots were
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injected (triplicate) and eluted with the mobile phase under the reported chromatographic
conditions. The average peak height ratio between the internal standard and benzyl alco-
hol or benzaldehyde vs. the concentration of benzyl alcohol or benzaldehyde was plotted.
Analysis of bulk substance and dosage forms
The method mentioned above was applied to the determination of the purity of the
studied raw materials.
Injectable solutions were diluted with methanol to contain 0.4 mg mL–1 benzyl alcohol,
then aliquots of these solutions were successively diluted with the mobile phase, internal
standard was added and the procedure followed as described in the previous section.
The percentage recoveries were calculated by referring to the calibration graphs.
RESULTS AND DISCUSSION
Micellar liquid chromatography (MLC) represents an attractive alternative to con-
ventional aqueous-organic mobile phases in analysis. The retention of solutes is modi-
fied by the composition of eluents (17). The proposed method permits separation and
quantitation of benzyl alcohol and benzaldehyde in parenteral formulations.
Optimization of chromatographic performances
Different columns were tried for performance investigations including Zorbax Ec-
lipse XDB-C8 column (150 mm×4.6 mm i.d., 5 µm particle size) (Agilent, USA), Bond-
clone, C18 column (300 mm×3.9 mm i.d., 10 µm particle size) (Phenomenex, USA), Apex
ODS-2, C18 column (120 mm×4.6 mm i.d., 5 µm particle size) (Merck, Germany). The re-
sults obtained show that the third column was the most suitable one since a good resolu-
tion of peaks was obtained.
Fig. 1 shows a chromatogram indicating good resolution of benzyl alcohol (tR = 2.1
min) and benzaldehyde (tR = 3.8 min).
The UV detector response of benzyl alcohol and benzaldehyde was studied and the
best wavelength was found to be 254 nm, showing the highest sensitivity. The use of dif-
ferent internal standards such as methyl paraben and propyl paraben was studied to ob-
tain accurate and elegant results. The use of methyl paraben was investigated and it was
found to be unsuitable since it is poorly resolved from benzaldehyde. Propyl paraben is
the internal standard of choice.
Several modifications in the micellar mobile phase composition were performed in
order to study the possibilities of changing the selectivity of the chromatographic sys-
tem. These modifications included the change of surfactant concentration, the concen-
tration of co-surfactant, the pH and the flow rate (Fig. 1). The best pH for investigation
was found to be 7.5, since lower pH produced a shoulder in the required peak and at pH
6.0 a forked peak was produced. The effect of changing concentration of SDS on the se-
lectivity and retention times of the test solutes was investigated using mobile phases
containing SDS concentrations from 1–4% (0.05–0.15 mol L–1). Fig. 1a shows that an in-
crease in the SDS concentration will decrease retention. Concentration of 0.07 mol L–1
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(2%) SDS was found to be suitable for routine work as it provides adequate elution time
in addition to the best resolution and the highest number of theoretical plates. Fig. 1b
shows the effect of changing the co-surfactant (1-propanol) concentration within the ran-
ge of 6–15%. The retention times of the test solutes decreased with increasing the co-
-surfactant concentration. The decrease is lower than that observed when changing the
concentration of SDS and no significant effect on the selectivity is observed. A concen-
tration of 10% was found to be suitable. The effect of flow rate on the formation and sepa-
ration of peaks of the studied compounds was studied and a flow rate of 1 mL min–1
was optimal for good separation in a reasonable time (Fig. 1c).
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Fig. 1. Chromatograms showing:
a) 1 – solvent front
2 – 40 mg mL–1 benzyl alcohol (tR = 2.1 min)
3 – 2 mg mL–1 benzaldehyde (tR = 3.8 min)
4 – 5 mg mL–1 propyl paraben (tR = 5.6 min)
b) 1 – solvent front
2 – 40 mg mL–1 benzyl alcohol (tR = 2.1 min)
3 – 25 mg mL–1 diclofenac sodium (tR = 5.7 min)
4 – 5 mg mL–1 propyl paraben (tR = 5.6 min)
c) 1 – solvent front
2 – 1.33 mg mL–1 lincomycin (tR = 1.1 min)
3 – 40 mg mL–1 benzyl alcohol(tR = 2.1 min)
4 – 5 mg mL–1 propyl paraben (tR = 5.6 min)
d) 1 – solvent front
2 – 60 mg mL–1 piroxicam (tR = 1.2 min)
3 – 60 mg mL–1 benzyl alcohol (tR = 2.1 min)




Under the above described experimental conditions, linear regression analysis of the
data gave the following equations:
benzyl alcohol: PHR = 0.0158 + 0.011 g (R = 0.9999)
benzaldehyde : PHR = 0.089 + 0.133 g (R = 0.9999)
where g is the concentration of the compound in µg mL–1 and PHR is the peak height ra-
tio. The corresponding concentration ranges are 10–100 and 1–20 mg mL–1 for benzyl al-
cohol and benzaldehyde, respectively.
The high values of the correlation coefficients with small intercepts indicate good
linearity of the calibration graphs. Statistical analysis of the data gave low values of the
standard deviations of the residuals (Sy/x) 3.46 × 10–3 and 9.11 × 10–3, of slope 4.43 × 10–5
and 5.3 × 10–4, and of intercept 9.17 × 10–4 and 5.21 × 10–3 for benzyl alcohol and benzal-
dehyde, respectively.
The limit of detection (LOD), defined as the analyte concentration giving a signal
equal to the blank signal plus two standard deviations of the blank (18), was found to be
0.25 µg mL–1 (2.3 × 10–6 mol L–1) and 0.12 µg mL–1 (1.13 × 10–6 mol L–1) for benzyl alco-
hol and benzaldehyde, respectively.
The limit of quantitation (LOQ), which is the lowest amount of analyte in a sample
that can be determined with acceptable precision and accuracy under the stated experi-
mental conditions (8), was 0.83 and 0.40 µg mL–1 for benzyl alcohol and benzaldehyde,
respectively.
The precision and accuracy of the proposed method were calculated using standard
solutions containing three different concentrations of each benzyl alcohol and benzal-
dehyde (three replicates). The mean results obtained are summarized in Table I. Low rela-
tive standard deviation of up to 0.5% and 0.2% for benzyl alcohol and benzaldehyde, re-
spectively, can be considered adequate for the quality control of pharmaceutical prepa-
rations. Accuracy expressed as recovery ranged from 99.5 to 100.6% for benzyl alcohol
and from 98.2 to 100.7% for benzaldehyde, mean relative error was 0.1–0.6% and 0.1–
0.2% for benzyl alcohol and benzaldehyde, respectively.
Dosage forms analysis
The results of the proposed method were compared with those obtained from the
official HPLC method (8). Statistical analysis of the results obtained by the proposed and
official methods showed no significant difference between the performance of the two
methods using Student’s t test and variance ratio F values (Table II).
The proposed method was successfully applied to the assay of benzyl alcohol and
benzaldehyde in different pharmaceutical preparations (injectable formulations). The
average percent recoveries of different concentrations were based on the average of three
replicate determinations. Recovery values ranged between 99.3 and 100.5% with RSD 0.2–
0.7% for both analytes in the presence of any of the four drugs (piroxicam, diclofenac,
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Fig. 2. Number of theoretical plates of benzyl alcohol and benzaldehyde as a function of: a) concen-
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Table I. Accuracy and precision data for benzyl alcohol and benzaldehyde in standard



















40.0 99.9 ± 0.3 0.3 0.1 99.9 ± 0.7 0.7 0.4
60.0 99.6 ± 0.2 0.2 0.1 99.8 ± 1.0 1.0 0.6
80.0 99.5 ± 0.5 0.5 0.3 100.6 ± 0.8 0.8 0.4
Benzaldehyde
5.0 98.2 ± 0.2 0.2 0.1 98.2 ± 0.1 0.1 0.1
10.0 100.0 ± 0.1 0.1 0.1 100.1 ± 0.2 0.1 0.1
12.0 100.7 ± 0.1 0.1 0.1 100.6 ± 0.2 0.1 0.1
a n = 3 at each concentration level.
b Mean relative error (n = 3).
Table II. Assay of benzyl alcohol and benzaldehyde in formulations using the proposed
MLC and the official HPLC methods
Analyte Formulationa
Recovery (mean ± SD)b
t-valuec F-valuec
Proposed method Official method (8)
Benzyl alcohol A 99.3 ± 0.2 100.1 ± 0.7 1.991 10.279
B 100.5 ± 0.4 99.9 ± 0.4 2.066 1.465
C 100.5 ± 0.3 100.0 ± 0.5 1.468 4.043
D 99.3 ± 0.2 100.0 ± 0.6 1.923 12.724
E 99.5 ± 0.2 100.1 ± 0.5 2.125 4.325
F 100.4 ± 0.4 100.6 ± 0.3 0.637 2.269
G 99.5 ± 0.4 100.3 ± 0.6 2.071 2.227
Benzaldehyde A 100.5 ± 0.3 100.1 ± 0.6 1.138 4.478
B 100.2 ± 0.2 100.2 ± 0.5 0.101 6.488
C 100.4 ± 0.4 100.1 ± 0.4 0.802 1.081
D 99.8 ± 0.7 100.9 ± 0.8 1.797 1.429
E 99.6 ± 0.4 100.2 ± 0.4 1.930 1.018
F 99.6 ± 0.4 100.1 ± 0.6 1.264 1.937
G 99.8 ± 0.6 99.9 ± 0.6 0.189 1.244
a In A and B benzyl alcohol (20 mg mL–1) is co-formulated with piroxicam.
In C benzyl alcohol (40 mg mL–1) is co-formulated with piroxicam.
In D benzyl alcohol (40 mg mL–1) is co-formulated with diclofenac sodium.
In E benzyl alcohol (50 mg mL–1) is co-formulated with diclofenac sodium.
In F benzyl alcohol (9 mg mL–1) is co-formulated with lincomycin.
In G benzyl alcohol (9 mg mL–1) is co-formulated with clindamycin.
b n = 3
c Tabulated t- and F-values at p = 0.05 are: t = 2.132 and F = 19.00.
lincomycin, clindamycin). Fig. 1 shows chromatograms indicating good resolved peaks
of benzyl alcohol in the presence of diclofenac sodium, lincomycin and piroxicam, res-
pectively.
Degradation of benzyl alcohol to benzaldehyde is easily detectable and can be analyz-
ed quantitatively, but the allowable limit is hardly detectable in injectable formulations.
However, the standard addition technique can be followed to detect such minute amounts,
if present.
CONCLUSIONS
The present investigation confirms that the use of micellar mobile phases in HPLC
provides separation efficiency and selectivity comparable to conventional reversed-phase
HPLC systems for the determination of benzyl alcohol and benzaldehyde in the studied
formulations. The proposed procedure offers additional advantages over the official pro-
cedure, in that the former is, more sensitive, with good accuracy and precision.
Acknowledgements. – The authors thank the Egyptian pharmaceutical firms (Sedico, Memphis
Chemical Co., Pfizer, Medical Union Pharmaceuticals Company and Novartis) for their kind coope-
ration in providing the raw materials and the formulations used in this study.
REFERENCES
1. A. G. Kazemifard, D. E. Moore and A. Mohammadi, Polarographic determination of benzal-
dehyde in benzyl alcohol and sodium diclofenac injection formulations, J. Pharm. Biomed. Anal.
30 (2002) 257–262; DOI: 10.1016/S0731-7085(02)00340-0.
2. M. A. El-Ries, Spectrophotometric and indirect determination of lincomycin by atomic absorp-
tion spectroscopy (AAS), Anal. Lett. 27 (1994) 1517–1531.
3. Y. C. de-Micalizzi, N. B. Pappano and N. B. Debattista, First and second order derivative spec-
trophotometric determination of benzyl alcohol and diclofenac in pharmaceutical forms, Talanta
47 (1998) 525–530; DOI: 10.1016/S0039-9140(98)00080-0.
4. N. Kosmeas and J. T. Clerc, Complete analytical characterization of an antirheumatic injection
solution, Pharm. Acta. Helv. 66 (1991) 214–218.
5. K. Urakami, A. Higashi, K. Umemoto and M. Godo, Matrix media selection for the determina-
tion of residual solvents in pharmaceuticals by static headspace gas chromatography, J. Chro-
matogr. A 1057 (2004) 203–210.
6. G. C. Wood, M. R. Iyer, A. M. Geller, A. M. Fleishner and B. B. Sheth, A high pressure liquid
chromatography assay method for analysis of deslorelin and benzyl alcohol in deslorelin injec-
tion, J. Liq. Chromatogr. Relat. Technol. 21 (1998) 2183–2190.
7. G. N. Menon and B. J. Norris, Simultaneous determination of hydroxyzine hydrochloride and
benzyl alcohol in injection solutions by high-performance liquid chromatography, J. Pharm. Sci.
70 (1981) 697–698.
8. United States Pharmacopoeia 27, National Formulary 22, USP Convention, Rockville 2004, p. 2830.
9. British Pharmacopoeia, Her Majesty’s Stationary office, London 1998, pp.161–162.
10. K. Urakami, C. Kobayashi, Y. Miyazaki, K. Nishijima and Y. Yoshimura, Degradation products
generated by sonication of benzyl alcohol, a sample preparation solvent for the determination
of residual solvents in pharmaceuticals bulks, on capillary gas chromatography, Chem. Pharm.
Bull. 48 (2000) 1299–1303.
238
M. Rizk et al.: Micellar liquid chromatographic analysis of benzyl alcohol and benzaldehyde in injectable formulations, Acta Pharm.
57 (2007) 231–239.
11. A. G. Kazemifard, D. E. Moore, A. Mohammadi and A. Kebriyaeezadeh, Capillary gas chroma-
tography determination of benzaldehyde arising from benzyl alcohol used as preservative in
injectable formulations, J. Pharm. Biomed. Anal. 31 (2003) 685–691; DOI: 10.1016/S0731-7085(02)
00729-X.
12. D. Gormand, J. Brazier, F. Comet and D. Lecompte, High performance liquid chromatographic
determination of benzyl alcohol and its degradation product benzaldehyde in a pharmaceutical
cream, J. Chromatogr. 355 (1986) 345–349; DOI: 10.1016/S0021-9673(01)97335-2.
13. M. F. Borgerding and W. L. Hinze, Characterization and evaluation of the use of non-ionic poly-
oxyethylene (23) dodecanol [Brij 35] micellar mobile phases in reversed-phase high-performan-
ce liquid chromatography, Anal. Chem. 57 (1985) 2183–2190.
14. I. I. Hewala, Gas-liquid chromatographic and difference spectrophotometric techniques for the
determination of benzaldehyde in benzyl alcohol, J. Pharm. Biomed. Anal. 12 (1994) 73–79; DOI:
10.1016/0731-7085(94)80012-X.
15. I. I. Hewala, Difference spectrophotometric assay of benzaldehyde in benzyl alcohol, Talanta 40
(1993) 919–923; DOI: 10.1016/0039-9140(93)80052-S.
16. A. M. Di-Pietra, V. Cavrini and M. A. Raggi, Determination of benzaldehyde traces in benzyl al-
cohol by liquid chromatography (HPLC) and derivative UV spectrophotometry, Int. J. Pharm. 35
(1987) 13–20.
17. L. J. Love and J. J. Fett, Optimization of selectivity in micellar chromatographic procedures for
the determination of drugs in urine by direct injection, J. Pharm. Biomed. Anal. 9 (1991) 323–333;
DOI: 10.1016/0731-7085(91)80201-J.
18. J. C. Miller and J. N. Miller, Errors in Instrumental Analysis; Regression and Correlation, in Statistics
for Analytical Chemistry, 3rd ed., Ellis-Horwood, New York 1993, p. 115.
S A @ E T A K
Micelarna teku}inska kromatografska analiza benzilnog alkohola
i benzaldehida u injekcijskim pripravcima
MOHAMED RIZK, FAWZIA IBRAHIM, MOHAMED HEFNAWY i JENNY JEEHAN NASR
Razvijena je to~na, osjetljiva i selektivna reverzno-fazna micelarna kromatografska
metoda za simultano odre|ivanje benzilnog alkohola i benzaldehida. Metoda je primi-
jenjena u injekcijskim pripravcima diklofenaka, piroksikama, linkomicina i klindamici-
na. U koncentracijskom podru~ju 10–100 i 1–20 mg mL–1 postignuta je izvrsna linearnost,
te granica detekcije (S/N = 3) od 0,25 mg m L–1 (2,3 × 10–6 mol L–1) i 0,12 µg mL–1 (1,13 ×
10–6 mol L–1) za benzilni alkohol, odnosno benzaldehid. Metoda je uspje{no primijenje-
na za analizu benzilnog alkohola i benzaldehida kao ~istih supstancija s analiti~kim
povratom od 100.1 ± 1.0%, odnosno 100.4 ± 1.6% i u injekcijskim pripravcima s
analiti~kim povratom od 99.8 ± 0.3, odnosno 100.0 ± 0.4%.
Klju~ne rije~i: micelarna teku}inska kromatografija, benzilni alkohol, benzaldehid, injekcijski pripravci
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